Korea Investment CORP Purchases Shares of 84,605 Astera Labs, Inc. $ALAB

Posted by Brian Himes on Aug 23rd, 2026

Korea Investment CORP bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) during the second quarter, HoldingsChannel.com reports. The institutional investor bought 84,605 shares of the company’s stock, valued at approximately $40,866,000.

Several other hedge funds have also added to or reduced their stakes in the company. BlackRock Inc. acquired a new stake in shares of Astera Labs during the second quarter worth $6,609,581,000. Atreides Management LP grew its stake in shares of Astera Labs by 108.9% in the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after acquiring an additional 1,754,593 shares in the last quarter. Amundi increased its position in Astera Labs by 1,298.6% during the third quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after acquiring an additional 1,319,643 shares during the period. Artisan Partners Limited Partnership bought a new position in Astera Labs during the fourth quarter worth about $148,980,000. Finally, Goldman Sachs Group Inc. raised its stake in Astera Labs by 189.0% in the 4th quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company’s stock worth $218,419,000 after purchasing an additional 858,693 shares in the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, Director Stefan A. Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $311.83, for a total value of $2,804,599.02. Following the completion of the sale, the director directly owned 3,970 shares of the company’s stock, valued at approximately $1,237,965.10. The trade was a 69.38% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 136,974 shares of the business’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $442.01, for a total value of $60,543,877.74. Following the completion of the sale, the director directly owned 1,287,524 shares of the company’s stock, valued at $569,098,483.24. The trade was a 9.62% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 419,244 shares of company stock valued at $163,135,169. 10.40% of the stock is owned by corporate insiders.

Astera Labs Stock Down 1.9%

Shares of ALAB stock opened at $284.97 on Friday. Astera Labs, Inc. has a twelve month low of $97.89 and a twelve month high of $499.48. The stock’s fifty day simple moving average is $352.70 and its 200 day simple moving average is $244.92. The firm has a market capitalization of $49.44 billion, a P/E ratio of 141.07 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB – Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.69 by $0.11. The firm had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company’s revenue for the quarter was up 104.5% on a year-over-year basis. During the same quarter last year, the firm earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, equities research analysts expect that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on ALAB. Royal Bank Of Canada boosted their price target on Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a research note on Wednesday, August 5th. Northland Securities raised Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 price objective for the company in a report on Monday, August 17th. Citigroup reiterated a “buy” rating on shares of Astera Labs in a research report on Wednesday, July 29th. UBS Group reissued a “neutral” rating and set a $425.00 target price on shares of Astera Labs in a report on Wednesday, August 5th. Finally, Needham & Company LLC raised their price target on Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Astera Labs presently has a consensus rating of “Moderate Buy” and an average price target of $333.00.

View Our Latest Research Report on Astera Labs

Astera Labs Profile

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.